Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

to test the safety of irbesartan ( an angiotensin II receptor antagonist ) and amlodipine for a major trial studying the effects of irbesartan on morbidity and mortality in hypertensive type 2 diabetic patients with diabetic nephropathy(passive) was designedA pilot study of 47 patients

the aberrant GR profile had " normalizedledto a pilot study about cfDNA in Hodgin lymphoma patients

as an exploratory evaluation of a subset of the more challenging patients , many of whom may not have responded to multiple previous therapies(passive) is being designeda ' pilot ' study in 100 patients

sapropterin dihydrochlorideto preventmeal - induced lipid peroxidation and endothelial dysfunction in patients with phenylketonuria : a pilot study

Gumsleda pilot study for patients suffering from hypertension with mixed results

a less invasive cardiac device located outside the heart and supports the weakened ventricular muscle during treatment of valvular dysfunction(passive) was designedstudyThe pilot study of 20 patients

Jennifer Tjia , MD , MSCEis leadinga pilot study entitled , " Patterns of care and medication use of older patients with diabetes

EdDis leadinga pilot study entitled , " Patient education about anticoagulation medication

Evaluation takes time – you haveto designa pilot study and a retrospective observational study , randomise patients

little effect on the mechanismcausesulcerative colitis in a pilot study of 59 patients

This study ( 22(passive) was designedThis study ( 22

in a technical success rate of 85 %resultedin a technical success rate of 85 %

o ino are multiple causes ocauseso ino are multiple causes o

to slight modificationsledto slight modifications

in similar means and slightly different standard deviations of mean blood pressureresultedin similar means and slightly different standard deviations of mean blood pressure

in a dramatically decreased CSF VEGF level and relief of clinical symptomsresultedin a dramatically decreased CSF VEGF level and relief of clinical symptoms

to evaluate the feasibility of electronic data collection from a computer used in the patients ’ homes CGMS used by 10 patients prior to 3-month visit for 48 - 72 hours On 2 days of CGMS usedesignedto evaluate the feasibility of electronic data collection from a computer used in the patients ’ homes CGMS used by 10 patients prior to 3-month visit for 48 - 72 hours On 2 days of CGMS use

to improve a particular type of memory , called working memoryis designedto improve a particular type of memory , called working memory

the treatment of pneumonia(passive) caused bythe treatment of pneumonia

Blob

Smart Reasoning:

C&E

See more*